Van­da sues FDA yet again, ac­cus­es fed­er­al agency of de­lay­ing post-CRL hear­ing

Van­da Phar­ma­ceu­ti­cals has filed yet an­oth­er law­suit against the FDA — and once again re­lat­ed to the drug it’s hop­ing to ex­pand in­to jet lag dis­or­der.

The se­r­i­al plain­tiff ac­cused the agency of fail­ing to give Van­da a hear­ing to de­ter­mine if it can add a jet lag dis­or­der in­di­ca­tion to Het­lioz, Van­da’s FDA-ap­proved drug to treat Non-24, a cir­ca­di­an rhythm dis­or­der in which a pa­tient’s in­ter­nal clock is mis­matched to the 24-hour day/night cy­cle.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER